Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
To confirm the antidepressant-like activity of agomelatine (S 20098), a melatonin agonist and 5-hydroxytryptamine2C antagonist, already reported in the chronic mild stress and forced swimming tests, the effects of agomelatine were investigated in the learned helplessness test and compared with those of imipramine, melatonin and a selective 5-hydroxytryptamine2C antagonist, SB-242 084. Agomelatine was administered for 5 days either once a day or twice a day, and the effects of pretreatment by a melatonin receptor antagonist, S 22153 (20 mg/kg/day), were studied. A deficit in avoidance learning was observed in helpless control animals. Agomelatine (10 mg/kg/day) administered once a day significantly reduced this deficit with an effect similar to that of imipramine. Effects of agomelatine were abolished by S 22153 pretreatment. Melatonin or SB-242 084 did not reduce the deficit of helpless control animals. These results confirm the antidepressant-like activity of agomelatine and suggest a role of melatonin receptors in its mechanism of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Souêtre, E., Salvati, E., Belugou, J.-L., Pringuey, D., Candito, M., Krebs, B., Ardisson, J.-L., & Darcourt, G. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90207-2 · Cited by 396 · cited 1×
“More specifically, it has been shown that the amplitude of the circadian rhythms is often blunted in depressed patients, whereas this chronobiological abnormality is no longer observed after recovery (Souetre et al., 1989).”
BackgroundCircadian Rhythm Mechanisms in Affective Illness and in Antidepressant Drug Action
Wehr, T., & Wirz-Justice*, A. (1982) · Pharmacopsychiatry · doi:10.1055/s-2007-1019506 · Cited by 256
Melatonin analogues as agonists and antagonists in the circadian system and other brain areas
Ying, S.-W., Rusak, B., Delagrange, P., Mocaër, E., Renard, P., & Guardiola-Lemaître, B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00684-2 · Cited by 114 · cited 6×
“, 2003) and is only five-fold higher than that necessary to achieve maximal chronobiotic activity (Martinet et al., 1996; Ying et al., 1996).”
BackgroundInfluentialSelf-citation
Cited by
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Liu, J., Clough, S. J., Hutchinson, A. J., Adamah-Biassi, E. B., Popovska-Gorevski, M., & Dubocovich, M. L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124742 · Cited by 630
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
de Bodinat, C., Guardiola-Lemaitre, B., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3140 · Cited by 593
Self-citationMelatonin and its analogs in insomnia and depression
Cardinali, D. P., Srinivasan, V., Brzezinski, A., & Brown, G. M. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00962.x · Cited by 353
Physiology and pharmacology of melatonin in relation to biological rhythms
Zawilska, J. B., Skene, D. J., & Arendt, J. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70081-7 · Cited by 336
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
Jockers, R., Maurice, P., Boutin, J. A., & Delagrange, P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.184 · Cited by 293
“The efficacy of agomelatine as an antidepressant may result in part from its activity as an MT1/MT2 agonist, although melatonin receptor activation alone is not sufficient for effectiveness in treating depression (Dalton et al., 2000; Bertaina-Anglade et al., 2006).”
Background
Metadata
- Authors
- Bertaina-Anglade, V., Drieu la Rochelle, C., Boyer, P.-A., & Mocaër, E.
- Venue
- Behavioural Pharmacology
- Published
- 2006-12
- Volume
- 17
- Issue
- 8
- Pages
- 703-713
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W1998894503
- Cited by
- 121
- References
- 3
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model. https://app.cochat.ai/papers/10.1097/fbp.0b013e3280116e5c
- The paper
- Bertaina-Anglade, V., Drieu la Rochelle, C., Boyer, P.-A., & Mocaër, E. (2006). Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model. Behavioural Pharmacology. https://doi.org/10.1097/fbp.0b013e3280116e5c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.